We performed a cross-sectional survey to investigate actual clinical practice concerning blood-pressure control among patients with hypertension in Kanagawa. The guidelines of the Japanese Society of Hypertension (JSH) for the management of patients with hypertension were revised in 2014. From October 1 to November 30, 2014, questionnaires on the care of patients with hypertension were sent via post to members of the Kanagawa Physicians Association in Kanagawa Prefecture, Japan. -Data on 1,105 patients (mean age: 68.4±12.3 years, 537 men and 568 women) were obtained. The overall mean systolic blood pressure (BP) of these patients was 128.7±12.1 mmHg for home monitoring and 132.9 12.6 mmHg for office monitoring; diastolic BP was 75.7 9.7 for home monitoring and 77.0 9.7 mmHg for office monitoring. According to the JSH 2014 guidelines, the target BP was achieved by 68.1% of all subjects; 89.2% of late-phase elderly patients (75 years or older); 69.1% of young, middle-aged, and earlyphase elderly patients (younger than 75 years except in patients with diabetes mellitus [DM] or chronic kidney disease [CKD] with proteinuria); 9.3% of patients with DM except late-phase elderly patients; and 11.9% of CKD patients with proteinuria except DM. Cross-sectional analysis showed that the factors significantly associated with an increased likelihood of achieving the target BP were as follows: 1) good medication compliance even for a small number of antihypertensive agents at small amount of doses in patients 75 years and older; 2) good medication compliance in patients in younger than 75 years; 3) an older age, a larger proportion in the female-to-male ratio and a lower body mass index in patients with DM except late-phase elderly patients; and 4) usage of a large number of antihypertensive agents in CKD patients with proteinuria. Further follow-up surveys are necessary to investigate changes in clinical practice following the introduction of the revised guidelines. (J Nippon Med Sch 2016; 83: 188 195) 
Introduction
Elevated blood pressure (BP) is considered a common risk factor for stroke and cardiovascular disease 1, 2 , and it is recognized that the normalization of blood pressure is the most important factor in reducing morbidity and mortality 3, 4 . In this context, several hypertension management guidelines have been established for patients with hypertension 5 7 .
The Japanese Society of Hypertension (JSH) first pub- 
Patients and Methods

Data and Subjects
The present study was performed in Kanagawa Prefecture, Japan, from October 1 to November 30, 2014. The survey was based on our previous studies, which have been described in detail 11, 12 . A questionnaire was mailed to 1,572 members of the Kanagawa Physicians Associa- The score of antihypertensive drugs was adjusted to the standard dose. Abbreviations: DM, diabetes mellites; CKD, chronic kidney disease; CAD, coronary arterial disease; CVD, cerebrovascular disease; BP, blood pressure control in patients younger than 75 years including patients with CAD and CVD was 69.1%. The rate of BP control in CKD patients with non-diabetic proteinuria who were not late-phase elderly was 11.9%. In all cases, the rate of controlled BP in the office was higher than that in the home.
Comparisons between Patients in whom BP was Controlled or Non-Controlled in Patients 75 Years and
Older, and in Patients Younger than 75 Years (Table 3) Among patients 75 years and older, the total number of antihypertensive agents and the scores used for the treatment of hypertension in patients were significantly higher in the noncontrol group. However, the medication compliance was significantly greater in the BP control group than in the non-control group (91.0% vs. 76.2%) in patients 75 years and older, and it was similar in the patients younger than 75 years group. In patients younger than 75 years, the total number of antihypertensive drugs and their scores were not significantly different. The average age and sex ratio were significantly different in that the non-control group was younger than the control group and the ratio of males to females was larger in the non-control group.
Comparisons between Patients in whom BP was Controlled or Non-Controlled in Patients with DM, and
Non-Diabetic CKD with Proteinuria (Table 4) There were different patient' characteristics in patients with DM. For example, the average age was older, the female-to-male ratio was larger, and the body mass index (BMI) was smaller in the control group than in the noncontrol group. The other factors were not significantly different. In patients with non-diabetic CKD with proteinuria, the total number of antihypertensive drugs was significantly larger in the control group than in the noncontrol group. In terms of the classes of drugs, the usage of beta-blockers was higher in the control group than in the non-control group.
Discussion
The Organ damage is frequently observed in late-phase elderly patients, who are older than 75 years. The recom- Abbreviations: BP, blood pressure; DM, diabetes mellitus; CKD, chronic kidney disease; CAD, coronary arterial disease; CVD, cerebrovascular disease. The score of antihypertensive drugs was adjusted to the standard dose. #: The comparison between the groups was calculated by a non-parametric method using the Mann-Whitney test.
mended target level of BP control in these patients is less than 150/90 mmHg, and if possible, a further reduction to the final target level of less than 140/90 mmHg. If the age-based target BP differs because of the presence of concomitant disease, the age-based target BP should be set as the first goal. Of course, if these late-phase elderly Table 4 Comparisons between target BP achieved and non-achieved groups in DM patients, and CKD with proteinuria but not DM. and a larger population of females (54.6% vs. 38.9%) may contribute to good BP control in these patients ( Table 3 ).
In patients with DM, the achievement ratio of the tar- Table 4) .
However, in non-diabetic CKD patients with proteinuria, the achievement ratio of BP control was also very poor, such as 11.9%. In these patients one factor of success in BP control was more aggressive antihypertensive treatment. The total number of antihypertensive agents was 3.2 1.09 in the control group and 2.05 0.88 in the noncontrol group (Table 4) . Patient' characteristics were not significantly different between groups; however, the number of patients in these groups was limited. In these two poor BP control groups, more than 90% of physicians judged these BP levels as permissible ( Table 4 ). The Fukushima research of hypertension 22 study pointed out that the necessity of improvement in physicians' awareness concerning the management of hypertension according to treatment guidelines and the importance of a healthy lifestyle to maintain goal BP levels. These poor achievement ratios may be due to the strict target levels of BP control, especially in home BP levels, such as less than 125/75 mmHg. There were no significant differences in office BPs between the two groups but significant differences were seen in home BPs. This may be due to the poorly known new concept that, when there is a discrepancy in diagnosis between office BP and home BP, the home BP-based diagnosis should have priority.
Our study had some limitations. First, this was a crosssectional analysis. Second, this study was performed only six months after the new JSH guidelines were established. Third, CAD and CVD patients were included in the patients younger than 75 years group since the numbers of those patients were very small (CAD in 10 cases and CVD in 12 cases) and they had the same BP criteria.
Further follow-up survey data are necessary for a full assessment.
